On behalf of the GMMMG Clinical Reference Group, two GMMMG shared care protocols have been drafted for:

  • sodium zirconium cyclosilicate (Lokelma) for refractory hyperkalaemia
  • patiromer (Veltassa) for refractory hyperkalemia

We now seek comments on these drafts, which are available from the GMMMG consultations page. The consultation period is open until 5pm on Monday 12th September.